Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trialRussell E. Ware, Robert J. Adams, Barry R. Davis et al.|The Lancet|2015Cited by 518
Common variants at 10 genomic loci influence hemoglobin A1C levels via glycemic and nonglycemic pathways (Diabetes (2010) 59, (3229-3239))Nicole Soranzo, Sophie Gallina, Serena Sanna et al.|Oxford University Research Archive (ORA) (University of Oxford)|2011Cited by 24
An emerging role for endothelial barrier support therapy for congenital disorders of glycosylationWilliam Brucker, Olaf A. Bodamer, Nidhi Shah et al.|Journal of Inherited Metabolic Disease|2020Cited by 22
TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell AnemiaRussell E. Ware, Robert J. Adams, Barry R. Davis et al.|Blood|2015Cited by 17